Giuseppe Lamberti

机构：IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dana-Farber Cancer Institute, Azienda USL di Bologna, University of Bologna · ORCID：0000-0003-3069-7630

发表论文 873 篇 · 总被引 5176 次 · h-index 37

代表论文

• Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population Study (2026 · Annals of Otology Rhinology & Laryngology)
• Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors (2026 · Thoracic Cancer)
• Lurbinectedin in the therapeutic landscape of SCLC: key clinical evidence and evolving role in the era of emerging therapies (2026 · Critical Reviews in Oncology/Hematology)
• Supplementary Figure 6 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
• Supplementary Figure 3 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
• Supplementary Table 3 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)